National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research, Peking University, Beijing 100191, China; Department of Neurobiology, Peking University Health Science Center, Beijing 100191, China.
National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research, Peking University, Beijing 100191, China; Department of Pharmacology, Peking University Health Science Center, Beijing 100191, China.
Gen Hosp Psychiatry. 2023 Jul-Aug;83:156-163. doi: 10.1016/j.genhosppsych.2023.05.008. Epub 2023 May 9.
Previous reports had linked depression to thyroid function. However, the relationship between thyroid function and clinical characteristics in major depressive disorder (MDD) patients with suicidal attempts (SA) is still unclear.
This study aims to reveal the association between thyroid autoimmunity and clinical characteristics in depressed patients with SA.
We divided 1718 first-episode and drug-naive MDD patients into groups with suicide attempt (MDD-SA) and without suicide attempt (MDD-NSA). Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), and the positive subscale of the Positive and Negative Syndrome Scale (PANSS) were assessed; thyroid function and autoantibodies were detected.
The total scores of HAMD, HAMA and psychotic positive symptoms were significantly higher in patients with MDD-SA, accompanied by higher levels of TSH, TG-Ab and TPO-Ab, than in patients with MDD-NSA, without gender differences. Total scores of positive symptoms (TSPS) in MDD-SA patients with increased TSH or TG-Ab was significantly higher than in MDD-NSA patients and in MDD-SA patients with normal TSH and TG-Ab. The proportion of elevated-TSPS in MDD-SA patients was >4 times that in MDD-NSA patients. The proportion of MDD-SA patients with elevated-TSPS was >3 times that with not-elevated TSPS patients.
Thyroid autoimmune abnormalities and psychotic positive symptoms may be the clinical features of MDD-SA patients. Psychiatrists should be more alert to the possibility of suicidal behaviors when they first encounter such a patient.
先前的报告将抑郁与甲状腺功能联系起来。然而,甲状腺功能与有自杀企图的重性抑郁障碍(MDD)患者的临床特征之间的关系尚不清楚。
本研究旨在揭示有自杀企图的 MDD 患者中甲状腺自身免疫与临床特征之间的关联。
我们将 1718 例首发、未经药物治疗的 MDD 患者分为有自杀企图组(MDD-SA)和无自杀企图组(MDD-NSA)。评估汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)和阳性和阴性症状量表(PANSS)的阳性子量表;检测甲状腺功能和自身抗体。
MDD-SA 患者的 HAMD、HAMA 总分和精神病阳性症状总分明显高于 MDD-NSA 患者,同时伴有 TSH、TG-Ab 和 TPO-Ab 水平升高,但无性别差异。MDD-SA 患者中 TSH 或 TG-Ab 升高的阳性症状总分(TSPS)明显高于 MDD-NSA 患者和 TSH、TG-Ab 正常的 MDD-SA 患者。MDD-SA 患者中 TSPS 升高的比例> MDD-NSA 患者的 4 倍。MDD-SA 患者中 TSPS 升高的比例>无 TSPS 升高患者的 3 倍。
甲状腺自身免疫异常和精神病阳性症状可能是 MDD-SA 患者的临床特征。精神科医生在首次遇到此类患者时,应更加警惕自杀行为的可能性。